Bluesight - About the company
Bluesight is a series A company based in Alexandria (United States), founded in 2011 by Kevin Macdonald and Tim Kress-Spatz. It operates as an AI-based medication data and analytics platform for pharmacies. Bluesight has raised $10.5M in funding from Thoma Bravo and New Leaf Venture Partners. The company has 3 active competitors, including 1 that is funded. Its top competitors are DocRX and HelioMetrics.
Company Details
AI-based medication data and analytics platform for pharmacies. It offers pharmaceutical intelligence and provides hospital pharmacies solutions for managing drug diversion, RFID medication monitoring, and pharmacy purchasing. They provide cloud-based software that uses data from electronic medical records and automated dispensing cabinets to proactively detect drug diversion. Additionally, they offer a practice guide for drug diversion programs and use analytics to improve drug spending and workflows.
- Website
- bluesight.com
- Email ID
- *****@kitcheck.com
- Phone Number
- +1 **********
- Registered Address
- Washington, District of Columbia
Key Metrics
Founded Year
2011
Location
Alexandria, United States
Stage
Series A
Total Funding
$10.5M in 2 rounds
Latest Funding Round
Investors
Ranked
1st among 3 active competitors
Employee Count
216 as on Mar 31, 2026
Legal entities associated with Bluesight
Bluesight is associated with 2 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
KITCHECK, INC. CIN: 275550596 , United States, Active | Dec 31, 1999 | - | 153 (As on Dec 31, 2024) | - |
Bluesight, Inc. CIN: 32053836857 , United States, Active | Oct 18, 2021 | - | - | - |
Sign up to download Bluesight's company profile
Bluesight's funding and investors
Bluesight has raised a total funding of $10.5M over 2 rounds. Its first funding round was on Jul 16, 2013. Its latest funding round was a PE round on Jul 17, 2023 for $*****. 2 investors participated in its latest round. Bluesight has 7 institutional investors.
Here is the list of recent funding rounds of Bluesight:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Jul 17, 2023 | 6211421 | PE | 3061270 | 4263178 | 7491922 | 3271425 |
Jul 16, 2013 | 9961379 | Series A | 2927843 | 7126347 |
View details of Bluesight's funding rounds and investors
Bluesight's founders and board of directors
Founder? Claim ProfileThe founders of Bluesight are Kevin Macdonald and Tim Kress-Spatz. Kevin Macdonald is the CEO of Bluesight.
Here are the details of Bluesight's key team members:
- Kevin Macdonald: Co-Founder & CEO of Bluesight and founder of 1 other company. They are also an angel investor in 1 startup and serve on the board of 1 company.Contact Info: 1 email address
- Tim Kress-Spatz: Co-Founder of Bluesight.
Bluesight's Board of Directors
Bluesight's board has 7 active members. Kevin Macdonald, Adam Grossman, Robert Ward, Vijay Lathi, Marcia Radosevich, Timothy Kress-Spatz and Mark Rosenbaum are independent board members.Here is the list of Bluesight's board of directors:
Name | Type | Representing | Status | Duration |
|---|---|---|---|---|
Independent board member | - | Current | 12y 8m | |
vwou{of | Independent board member | - | Current | 8y 5m |
qsopicr | Independent board member | - | Current | 8y 7m |
zsoxkek | Independent board member | - | Current | 2y 4m |
tkaxovi | Independent board member | - | Current | 5y 5m |
tohopqd | Independent board member | - | Current | 5y 7m |
getvpjg | Independent board member | - | Current | 4y 7m |
View details of Bluesight's Founder profiles and Board Members
Bluesight's employee count trend
Bluesight has 216 employees as of Mar 26. Here is Bluesight's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Bluesight's Competitors and alternates
Top competitors of Bluesight include DocRX and HelioMetrics. Here is the list of Top 10 competitors of Bluesight, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Bluesight 2011, Alexandria (United States), Series A | AI-based medication data and analytics platform for pharmacies | $10.5M | 56/100 | |
2nd | DocRX 2008, Mobile (United States), Unfunded | Healthcare solutions provider specializing in physician dispensing and compliance | - | - | 29/100 |
3rd | HelioMetrics 2013, Minneapolis (United States), Unfunded | Healthcare analytics software for Rx drug diversion and patient privacy | - | - | 21/100 |
Looking for more details on Bluesight's competitors? Click here to see the top ones
Bluesight's Investments and acquisitions
Bluesight has acquired 3 companies including Protenus, Sectyr and Medacist. Bluesight has not made any investments as of now.Here is the list of its acquisitions:
Date of Investment/Acquisition | Type | Company Name | Founded Year | Location |
|---|---|---|---|---|
Jan 09, 2025 | Acquisition | 2014 | Baltimore (United States) | |
Oct 18, 2024 | Acquisition | 2017 | Scottsdale (United States) | |
Jul 17, 2023 | Acquisition | 1998 | Cheshire (United States) |
See all acquisitions by Bluesight
News related to Bluesight
Media has covered Bluesight for 1 event in last 1 year, It was about partnerships.
•
Bluesight Partners with GraphiteRx and Mark Cuban Cost Plus DrugsBenzinga•Mar 03, 2026•Bluesight, GraphiteRx
•
Bluesight’s Acquisition of ProtenusGlobal Legal Chronicle•Jan 23, 2025•Bluesight, Protenus, Kirkland & Ellis, DLA Piper and 1 other
•
Bluesight acquires Protenus to add patient privacy monitoring featuresHospital Management•Jan 10, 2025•Bluesight, Protenus
•
Bluesight Expands Compliance Capabilities and Strengthens Platform through Acquisition of ProtenusSalesTech Star•Jan 09, 2025•Bluesight, Protenus
•
•
Bluesight Acquires Sectyr to Enhance 340B Compliance and Audit CapabilitiesHIT Consultant•Oct 18, 2024•Sectyr, Bluesight
•
Bluesight Streamlines B2B Integration with Platform Consolidation and Cleo’s Blended ServicesBusiness Wire•Aug 20, 2024•Bluesight
•
Thoma Bravo invests in medication intelligence firm Bluesight | PEPE Hub•Jul 19, 2023•Bluesight, Thoma Bravo, New Leaf Ventures, Medacist and 3 others
•
Data platform backed by Kaiser Permanente merges with competitorBecker's Hospital Review•Jul 19, 2023•Bluesight, Medacist, Thoma Bravo
•
Are you a Founder ?
FAQs about Bluesight
Explore our recently published companies
- Hundikurk - Estonia based, Unfunded company
- Srsisuagentuur - Estonia based, Unfunded company
- Jk75 - Latvia based, Unfunded company
- Digital Unity - Santa Monica based, 2018 founded, Deadpooled company
- 1jockey - Sherbrooke based, 2019 founded, Funding Raised company
- Balzia - Clermont Ferrand based, 2019 founded, Funding Raised company
